PELTHOS THERAPEUTICS INC

Historical 13F Holders

Symbol
PTHS
CUSIP
171126204
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 171126204 since 12/18/2024, largest first.

Filer % of Class Filed
Ligand Pharmaceuticals Inc 13D/A 49.9% 11/10/2025
Event 11/6/2025
3i, LP 13G/A
9.9% 5/7/2026
Event 3/31/2026
Murchinson Ltd. 13G
9.1% 11/14/2025
Event 9/30/2025
Friedberg Ezra M 13D/A
8.3% 7/3/2025
Event 7/1/2025
Ikarian Capital, LLC 13G/A
7.7% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
AME Equities LLC 13G/A
0% 8/13/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 40.0 $840.00
2026 Q2 25 1.36 M $38.5 M
2026 Q1 17 912 k $19.2 M
2025 Q4 15 899 k $27.9 M
2025 Q3 15 463 k $13.0 M